ArticleBMC biotechnology2025

Production of SARS-CoV-2 virus-like particles as a vaccine candidate in stable cell lines through inducible E and M protein expression.

Yu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.